BioSig Technologies, Inc. financial data

Symbol
BSGM on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
55 Greens Farms Road, Westport, CT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31.1 % -34.5%
Quick Ratio 8.18 % -89.6%
Debt-to-equity -196 % -118%
Return On Equity 796 %
Return On Assets -773 % -6.47%
Operating Margin -47.4K % -310%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.2M shares -80.4%
Common Stock, Shares, Outstanding 16.6M shares -79%
Common Stock, Value, Issued 17K USD -78.5%
Weighted Average Number of Shares Outstanding, Basic 16.2M shares +115%
Weighted Average Number of Shares Outstanding, Diluted 16.2M shares +115%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 40K USD -85.5%
Revenue from Contract with Customer, Excluding Assessed Tax 1K USD
Research and Development Expense 1.91M USD -62%
General and Administrative Expense 15.5M USD -35.7%
Operating Income (Loss) -17.8M USD +39.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.4M USD +48%
Net Income (Loss) Attributable to Parent -15.3M USD +49%
Earnings Per Share, Basic -1.35 USD/shares +80.3%
Earnings Per Share, Diluted -1.35 USD/shares +80.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 200K USD -50%
Accounts Receivable, after Allowance for Credit Loss, Current 81K USD +479%
Inventory, Net 219K USD -87%
Other Assets, Current 5K USD
Assets, Current 848K USD -19.3%
Property, Plant and Equipment, Net 111K USD -81.3%
Operating Lease, Right-of-Use Asset 137K USD -71.9%
Other Assets, Noncurrent 44K USD -93.6%
Assets 1.42M USD -55%
Contract with Customer, Liability, Current 16K USD
Liabilities, Current 1.7M USD -56.5%
Operating Lease, Liability, Noncurrent 15K USD -94.7%
Liabilities 1.7M USD -58.6%
Retained Earnings (Accumulated Deficit) -254M USD -6.39%
Stockholders' Equity Attributable to Parent -405K USD +65.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -388K USD +63.2%
Liabilities and Equity 1.42M USD -55%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.31M USD +76.7%
Net Cash Provided by (Used in) Financing Activities 1.54M USD -77.2%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 16.6M shares -79%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 615K USD +58.1%
Deferred Tax Assets, Valuation Allowance 55.4M USD +16.2%
Operating Lease, Liability 145K USD -72.7%
Depreciation 232K USD -30%
Lessee, Operating Lease, Liability, to be Paid 151K USD -73.3%
Property, Plant and Equipment, Gross 1.04M USD -28.5%
Operating Lease, Liability, Current 145K USD -57.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 106K USD -71.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 106K USD +17.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD -82.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 106K USD -71.4%
Deferred Tax Assets, Operating Loss Carryforwards 43.3M USD +17.2%
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 254M USD +6.77%
Depreciation, Depletion and Amortization 312K USD -9.04%
Share-based Payment Arrangement, Expense 1.06M USD -50.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%